FGFR3 and lung carcinoma: Kang et al. found that miR-99b was down-regulated in patients with lung cancer, noticed that the overexpression of miR-99b induced a reduction in FGFR3 expression, and they suspected that miR-99b may be a potent tumor suppressor and a potential therapeutic tool for lung cancer patients25.